BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21287612)

  • 1. Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Proteins; 2011 Mar; 79(3):787-802. PubMed ID: 21287612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational movement of F251 contributes to the molecular mechanism of constitutive activation in the C5a receptor.
    Sen S; Baranski TJ; Nikiforovich GV
    Chem Biol Drug Des; 2008 Mar; 71(3):197-204. PubMed ID: 18248350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural mechanisms of constitutive activation in the C5a receptors with mutations in the extracellular loops: molecular modeling study.
    Nikiforovich GV; Baranski TJ
    Proteins; 2012 Jan; 80(1):71-80. PubMed ID: 21960464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational modeling of constitutively active mutants of GPCRs C5a receptor.
    Nikiforovich GV; Baranski TJ
    Methods Enzymol; 2010; 485():369-91. PubMed ID: 21050928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation and endocytosis of the complement factor 5a receptor: evidence for multiple activated conformations of a G protein-coupled receptor.
    Whistler JL; Gerber BO; Meng EC; Baranski TJ; von Zastrow M; Bourne HR
    Traffic; 2002 Dec; 3(12):866-77. PubMed ID: 12453150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.
    Nikiforovich GV; Baranski TJ
    Biochem Biophys Res Commun; 2009 Dec; 390(3):481-4. PubMed ID: 19799858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosterism in human complement component 5a ((h)C5a): a damper of C5a receptor (C5aR) signaling.
    Rana S; Sahoo AR; Majhi BK
    J Biomol Struct Dyn; 2016 Jun; 34(6):1201-13. PubMed ID: 26212097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role for the second extracellular loop in C5a receptor activation.
    Klco JM; Wiegand CB; Narzinski K; Baranski TJ
    Nat Struct Mol Biol; 2005 Apr; 12(4):320-6. PubMed ID: 15768031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D modeling of the activated states of constitutively active mutants of rhodopsin.
    Nikiforovich GV; Marshall GR
    Biochem Biophys Res Commun; 2006 Jun; 345(1):430-7. PubMed ID: 16682009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.
    Bamberg CE; Mackay CR; Lee H; Zahra D; Jackson J; Lim YS; Whitfeld PL; Craig S; Corsini E; Lu B; Gerard C; Gerard NP
    J Biol Chem; 2010 Mar; 285(10):7633-44. PubMed ID: 20044484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling.
    Rana S; Sahoo AR; Majhi BK
    Mol Biosyst; 2016 Apr; 12(5):1586-99. PubMed ID: 26978009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural sequence evolution and computational modeling approaches of the complement system in leishmaniasis.
    Ingale P; Kabra R; Singh S
    Adv Protein Chem Struct Biol; 2020; 120():409-424. PubMed ID: 32085887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the retinitis pigmentosa mutations in rhodopsin with a functional map of the C5a receptor.
    Hagemann IS; Nikiforovich GV; Baranski TJ
    Vision Res; 2006 Dec; 46(27):4519-31. PubMed ID: 16962629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered
    Sahoo AR; Mishra R; Rana S
    Sci Rep; 2018 Feb; 8(1):2955. PubMed ID: 29440703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction.
    Waters SM; Brodbeck RM; Steflik J; Yu J; Baltazar C; Peck AE; Severance D; Zhang LY; Currie K; Chenard BL; Hutchison AJ; Maynard G; Krause JE
    J Biol Chem; 2005 Dec; 280(49):40617-23. PubMed ID: 16230349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthosteric and allosteric action of the C5a receptor antagonists.
    Liu H; Kim HR; Deepak RNVK; Wang L; Chung KY; Fan H; Wei Z; Zhang C
    Nat Struct Mol Biol; 2018 Jun; 25(6):472-481. PubMed ID: 29867214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
    Postma B; Kleibeuker W; Poppelier MJ; Boonstra M; Van Kessel KP; Van Strijp JA; de Haas CJ
    J Biol Chem; 2005 Jan; 280(3):2020-7. PubMed ID: 15542591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.